201 related articles for article (PubMed ID: 16439436)
1. Hippocampal atrophy in systemic lupus erythematosus.
Appenzeller S; Carnevalle AD; Li LM; Costallat LT; Cendes F
Ann Rheum Dis; 2006 Dec; 65(12):1585-9. PubMed ID: 16439436
[TBL] [Abstract][Full Text] [Related]
2. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
[TBL] [Abstract][Full Text] [Related]
3. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
4. Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus.
Lapa AT; Pedro T; Francischinelli J; Coan AC; Costallat LT; Cendes F; Appenzeller S
Lupus; 2017 May; 26(6):633-639. PubMed ID: 27879427
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.
Appenzeller S; Bonilha L; Rio PA; Min Li L; Costallat LT; Cendes F
Neuroimage; 2007 Jan; 34(2):694-701. PubMed ID: 17112740
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study.
Loukkola J; Laine M; Ainiala H; Peltola J; Metsänoja R; Auvinen A; Hietaharju A
J Clin Exp Neuropsychol; 2003 Feb; 25(1):145-51. PubMed ID: 12607179
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.
Nishimura K; Harigai M; Omori M; Sato E; Hara M
Psychoneuroendocrinology; 2008 Apr; 33(3):395-403. PubMed ID: 18261856
[TBL] [Abstract][Full Text] [Related]
8. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
9. Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.
Appenzeller S; Amorim BJ; Ramos CD; Rio PA; de C Etchebehere EC; Camargo EE; Cendes F; Costallat LT
Rheumatology (Oxford); 2007 Mar; 46(3):467-72. PubMed ID: 16901949
[TBL] [Abstract][Full Text] [Related]
10. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric systemic lupus erythematosus: diagnostic and clinical features according to revised ACR criteria.
Buća A; Perković D; Martinović-Kaliterna D; Vlastelica M; Titlić M
Coll Antropol; 2009 Mar; 33(1):281-8. PubMed ID: 19408638
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
[TBL] [Abstract][Full Text] [Related]
13. Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus.
Kozora E; Brown MS; Filley CM; Zhang L; Miller DE; West SG; Pelzman J; Arciniegas DB
Lupus; 2011 May; 20(6):598-606. PubMed ID: 21335397
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease is associated with hippocampal atrophy.
Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
[TBL] [Abstract][Full Text] [Related]
15. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
Glanz BI; Slonim D; Urowitz MB; Gladman DD; Gough J; MacKinnon A
Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):232-8. PubMed ID: 9359119
[TBL] [Abstract][Full Text] [Related]
16. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
17. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in patients with systemic lupus erythematosus.
Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B
J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578
[TBL] [Abstract][Full Text] [Related]
19. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping].
Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y
Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785
[TBL] [Abstract][Full Text] [Related]
20. Subacute cerebellar ataxia and atrophy developed in a young woman with systemic lupus erythematosus whose cerebrospinal fluid was positive for antineuronal cell antibody.
Iwasaki Y; Okamoto A; Shoda H; Takahashi Y; Fujio K; Kawahata K; Yamamoto K
Lupus; 2012 Mar; 21(3):324-8. PubMed ID: 21965279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
